Effects of Long-term Use of Depo-medroxyprogesterone Acetate on Lipid Metabolism in Nepalese Women by Yadav, Binod Kumar et al.
www.kjlm.org     95
Effects of Long-term Use of Depo-medroxyprogesterone Acetate on Lipid 
Metabolism in Nepalese Women
Binod Kumar Yadav, M.Sc., Rajesh Kumar Gupta, B.Sc., Prajwal Gyawali, B.Sc., Rojeet Shrestha, M.Sc., Bibek Poudel, M.Sc., 
Manoj Sigdel, B.Sc., and Bharat Jha, M.Sc.
Department of Biochemistry, Institute of Medicine, Tribhuvan University Teaching Hospital, Kathmandu, Nepal
Various synthetic progestogens that are used as contraceptives have been reported to influence lipid and lipoprotein fractions dif-
ferently. Depo-medroxyprogesterone acetate (DMPA), a synthetic progestogen, is used by Nepalese women as a contraceptive 
agent. Our study aims to determine the effects of long-term use of DMPA on lipid metabolism. We performed this study on 60 
healthy Nepalese women who had been using DMPA for more than 2 yr and age- and weight-matched control subjects who were 
not using hormonal contraceptives. Fasting blood samples were collected from the subjects for the estimation of total cholesterol 
(TC) and triglyceride (TG) levels, and the levels of high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein choles-
terol (LDL-C) were estimated using the Friedewald’s equation. TC and LDL-C levels in DMPA users were significantly higher than 
those in non-users.  Our study concluded that DMPA use induces lipid metabolism changes that can increase the risk of cardiovas-
cular diseases.
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Depo-medroxyprogesterone acetate (DMPA, Depo-Pro-
vera®) is a highly effective contraceptive with a very low 
failure rate [1]; however, women who use this contraceptive 
may experience some adverse effects. DMPA is a weak an-
drogenic progestin that is administered as a single 150-mg 
intramuscular (i.m.) injection every 3 months. The contra-
ceptive appears to be a potent inhibitor of gonadotrophins 
[2, 3]. 
There has been considerable debate about the effect of 
DMPA on lipid metabolism; studies have reported both in-
crease and decrease in the levels of total cholesterol (TC), 
triglyceride (TG), and low-density lipoprotein cholesterol 
(LDL-C) in DMPA users. Many studies have also shown a 
decrease in high-density lipoprotein cholesterol (HDL-C) 
levels in long- and short-term DMPA users [4, 5]. Some 
studies have reported that DMPA does not exert any effect 
on various lipoproteins and lipid components [6, 7]. These 
DMPA-induced alterations in lipid metabolism can cause 
serious cardiovascular adverse effects in women. In this 
study, we aimed to identify the effects of DMPA use on the 
lipid profile of Nepalese women.
This study was performed at Tribhuvan University Teach-
ing Hospital, Institute of Medicine (TUTH, IOM), Kath-
mandu, Nepal, from February to October 2008. We selected 
60 women (25-35 yr of age) who weighed less than 75 kg, 
did not have any known diseases, and have not received any 
medication other than DMPA; these women were selected 
when they visited the family planning department of the 
hospital. They were regularly taking DMPA (150-mg (i.m.) 
injection) at 3-month intervals for more than 2 yr. We also 
recruited a control group of 100 age- and weight-matched 
healthy women (among the staff and students of TUTH, 
IOM) who were not using any hormonal contraceptives. 
Participants using lipid-lowering drugs were excluded from 
the study. After obtaining verbal consent from the subjects, 
fasting blood samples (5 mL) were collected from each sub-
ject to determine the plasma lipid and lipoprotein levels. 
This study was approved by our institutional review board. 
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mono kits were used for the enzymatic determination of TC 
[8] and TG [9] levels, respectively, in the Evolution 3000 
(Biochemical Systems International, Arezzo, Italy) chemical 
analyzer. HDL-C was measured indirectly by using a pre-
cipitating reagent (Human HDL cholesterol; Wiesbaden, 
Germany) [10]. We strictly followed the reagent instruction 
manuals for all the assays. Concentrations of LDL-C were 
estimated using Friedewald’s equation [11]. Both normal 
and high-level control sera were used in each run, and CV 
of imprecision was 4.1% for TC, 4.7% for TG, and 3.8% for 
HDL-C. Data were analyzed using SPSS software (SPSS 11.5 
version Inc., Chicago, IL, USA). The means of the 2 groups 
were compared using the Student’s t test, and the results 
were considered insignificant when P>0.05. All results are 
expressed as mean±SD. 
There were no significant differences in the age and weight 
of the control subjects and DMPA users. TC and LDL-C lev-
els in DMPA users were significantly higher than those in the 
control group (Table 1). The HDL-C and TG levels were not 
significantly different from the previously reported levels. 
The adverse effects of DMPA on lipid metabolism are re-
lated to its weak androgenic effect [12]. The studies on the 
effect of DMPA on plasma lipids have yielded inconsistent 
findings. In our study, the LDL-C and TC levels in DMPA 
users were significantly higher than those in the control sub-
jects. This finding is in agreement with the previous studies 
[6, 13, 14]. Unlike our study, the studies by Grönroos and 
Lehtonen [3] and Fajumi [15] showed a decrease in TC lev-
els, whereas those by Faddah et al. [6] and Garza-Flores et 
al. [5] did not show any changes in TC levels in DMPA us-
ers. Neither HDL-C nor TG levels were affected in DMPA 
users. However, many conflicting results have been reported 
[6, 12, 16]. Estrogens increase serum HDL-C levels and de-
crease serum TC and LDL-C levels, whereas progesterone 
has the opposite effect. DMPA, an weak synthetic progester-
one, opposes the effect of estrogens. The level of HDL-C is 
inversely related to the incidence of cardiovascular diseases 
[17]. Although there was no significant decrease in the 
HDL-C levels of DMPA users in our study, there was an in-
crease in the LDL-C levels. Our study concluded that DMPA 
induces lipid metabolism changes that can increase the risk 
of cardiovascular diseases.
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